BioSpace News Archive

Drug Development

4 Life Sciences Companies Hit the Ground Running in 2022

In addition to the beginnings of the Jazz PTSD study, Revive announced its Phase III study of Bucillamine in patients with mild to moderate COVID-19 will continue.

December 30, 2021
·
4 min read
·
Alex Keown
Deals

Rumors of Potential Biogen Buyout Kickstart 2022 M&A Speculation

Korea Economic Daily, published a story saying that Samsung Group was in talks to acquire Biogen. However, Samsung BioLogics stated in a regulatory filing yesterday that the rumor is not true.

December 30, 2021
·
3 min read
·
Mark Terry
Drug Development

Clinical Catch-Up: December 27-31

Not surprisingly, the week between Christmas and New Year was quiet in terms of clinical trial news. However, there were some announcements. Here’s a look.

December 30, 2021
·
3 min read
·
Mark Terry
Business

Codex DNA Finishes 2021 Strong with Promising Pfizer Partnership

Pfizer made an upfront payment of $8 million to Codex DNA. Additionally, the latter is eligible for milestone payments of up to $90 million in clinical milestone payments.

December 30, 2021
·
2 min read
·
Alex Keown
Business

BioSpace Movers & Shakers, Dec. 31

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

December 30, 2021
·
2 min read
·
Alex Keown
Drug Development

COVID Update: Previous Infection and Immunity, J&J Booster Effective Against Hospitalization

New Year is coming, and COVID-19 is still at play. For more COVID-19 studies, vaccines, and treatments, here are the latest updates.

December 30, 2021
·
4 min read
·
Vanessa Doctor, RN
Drug Development

Ocugen/Bharat Biotech Vaccine for COVID Looks Promising in Young Kids

Positive data from a Phase II/III trial of Bharat Biotech vaccine, Covaxin. Read more about the research and know about the efficiency of the vaccine.

December 30, 2021
·
2 min read
·
Mark Terry
Policy

Teva Planning Swift Appeal of Opioid Judgement in New York

Teva Pharmaceuticals will appeal a potential $1.5 billion judgment against the company in the state of New York for its alleged role in the opioid epidemic.

December 30, 2021
·
3 min read
·
Alex Keown
Cancer Supportive Care Products Market By Indication, By Drug Class, By Distribution, and By Region Forecast To 2028

The global pharma & healthcare market report points out the key trends and developments taking place in this business space in the ongoing COVID-19 times.

December 30, 2021
·
7 min read
Ophthalmic Drugs Market Size, Share And Industry Analysis By Drug Type, By Dosage, By Prescription Type, By Distribution Channel, By Drug Variation, and By Region Forecast To 2028

The global pharma & healthcare market report points out the key trends and developments taking place in this business space in the ongoing COVID-19 times.

December 30, 2021
·
7 min read